Clinical and Molecular Epidemiology of Myeloproliferative Neoplasms (MPNs)
The mandate of this MPN registry is to collect clinical information, including molecular results, from consenting patients with a variety of MPNs at different time points during the course of their disease.
⁃ Diagnosis of one of the following myeloproliferative neoplasms (MPNs):
• Atypical CML (aCML)
• Chronic eosinophilic leukemia-not otherwise specified (CEL, NOS),
• Chronic myelomonocytic leukemia (CMML)
• Chronic neutrophilic leukemia (CNL),
• Essential thrombocythemia (ET),
• Juvenile myelomonocytic leukemia (JMML),
• Mastocytosis, MPN unclassifiable
• MPN/MDS unclassifiable,
• Primary myelofibrosis (PMF),
• Post-essential thrombocythemia myelofibrosis (post-ET MF),
• Post-polycythemia vera MF (post-PV MF)
• Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T)